[Antineutrophil cytoplasmic antibody(ANCA)]

Area of Science:

• Immunology
• Rheumatology
• Clinical Chemistry

Context:

• Anti-neutrophil cytoplasmic antibodies (ANCA) are key diagnostic markers for small vessel vasculitis.
• Two main subtypes, myeloperoxidase (MPO)-ANCA and proteinase-3 (PR-3)-ANCA, exhibit distinct immunofluorescence patterns.
• PR-3 ANCA is highly specific for Wegener's granulomatosis (WG), while MPO-ANCA is more prevalent in microscopic polyangiitis (MPA) and other conditions.

Purpose:

• To evaluate the diagnostic and monitoring utility of antigen-specific ELISA for MPO-ANCA and PR-3 ANCA.
• To correlate ANCA titers with disease activity in ANCA-associated vasculitis (AAV).
• To assess the clinical manifestations and treatment efficacy in AAV.

Summary:

• Indirect immunofluorescence (IIF) for ANCA detection is enhanced by standardized antigen-specific ELISA.
• ELISA demonstrated low intra-assay and inter-assay coefficients of variation (CV) for MPO and PR-3.
• A strong correlation was observed between MPO-ANCA ELISA titers and AAV disease activity.
• Renal and pulmonary manifestations are common initial symptoms in 70-90% of AAV patients.
• ANCA titer changes reflect disease activity in 60-70% of AAV patients.
• Combination therapy with steroids and immunosuppressants effectively manages AAV symptoms.

Impact:

• Standardized ELISA assays improve the accuracy and reliability of ANCA testing.
• Correlating ANCA titers with disease activity allows for more precise patient management and treatment adjustments.
• This approach aids in early diagnosis and monitoring of AAV, potentially improving patient outcomes.
• Understanding the prevalence of MPO-ANCA and PR-3 ANCA in different vasculitis subtypes refines diagnostic criteria.